Publications and Presentations Database
How can psychological science inform research about genetic counseling for clinical genomic sequencing?. Journal of genetic counseling. 24(2), 193-204.(2015).
Associations between self-referral and health behavior responses to genetic risk information.. Genome medicine. 7(1), 10.(2015).
Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study.. Public health genomics. 18(2), 78-86.(2015).
Public beliefs and knowledge about risk and protective factors for Alzheimer's disease. Alzheimer's & Dementia : the journal of the Alzheimer's Association.(2014).
Distinct communication patterns during genetic counseling for late-onset Alzheimer's risk assessment. Patient education and counseling. 94(2), 170-9.(2014).
Emerging issues in public health genomics. Annual review of genomics and human genetics. 15, 461-80.(2014).
Direct-to-consumer genetic testing and personal genomics services: a review of recent empirical studies. Current genetic medicine reports. 1(3), 182-200.(2013).
Tactical, strategic, and life-goal self-regulation of driving by older adults: development and testing of a questionnaire. Journal of safety research. 46, 107-17.(2013).
Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues. Progress in neurobiology. 110, 89-101.(2013).
On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?. Medical decision making. 33(1), 71-7.(2013).
Associations between risk perceptions and worry about common diseases: a between- and within-subjects examination. Psychology & Health. 28(4), 434-49.(2013).
Amyloid imaging, risk disclosure and Alzheimer’s disease: ethical and practical issues. Neurodegenerative disease management. 3(3), 219 - 229.(2013).
Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: sociodemographic and numeracy correlates. Journal of genetic counseling. 21(3), 440-7.(2012).
Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing. Genetics in medicine : official journal of the American College of Medical Genetics. 14(2), 268-73.(2012).
Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease. Genetics in medicine : official journal of the American College of Medical Genetics. 14(8), 742-8.(2012).
Genetic testing for risk of Alzheimer’s disease: benefit or burden?. Neurodegenerative disease management. 2(2), 141-44.(2012).
Modeling decisions to undergo genetic testing for susceptibility to common health conditions: an ancillary study of the Multiplex Initiative. Psychology & Health. 27(4), 430-44.(2011).
Personalized oncology through integrative high-throughput sequencing: a pilot study. Science translational medicine. 3(111), 111ra121.(2011).
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in medicine : official journal of the American College of Medical Genetics. 13(6), 597-605.(2011).
Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genetics in medicine : official journal of the American College of Medical Genetics.(2011).